Yung-Jue Bang
New Generation University College
667 Papers
5.5K Citations
Yung-Jue Bang is an academic researcher from New Generation University College. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 94, co-authored 664 publications. Previous affiliations of Yung-Jue Bang include Seoul National University Hospital & Seoul National University.
Chat about Author
Papers
Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients.
Y H Park,J. J. Lee,M H Ryu,S Y Kim,D H Kim,Y R Do,Kyung Hee Lee,S J Oh,Y.-K. Kim,Cheolwon Suh,Dae Seog Heo,B Y Ryoo,J K Kim,H S Song,W S Lee,Hyeoung-Joon Kim,Yung-Jue Bang,S. H. Yang,Sang-Kyun Sohn,Y K Kang +19 more
TL;DR: The addition of rituximab to CHOP combination chemotherapy for DLBCLs showed improved outcomes, particularly in high-risk group according to the IPI, but there was no significant difference in low-risk patients.
Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy
Ho-Young Yhim,Sae-Won Han,Do-Youn Oh,Do-Youn Oh,Wonshik Han,Seock-Ah Im,Seock-Ah Im,Tae-You Kim,Tae-You Kim,Young Tae Kim,Dong-Young Noh,Eui Kyu Chie,Sung Whan Ha,In-Ae Park,Yung-Jue Bang,Yung-Jue Bang +15 more
TL;DR: The aim of this study was to evaluate the clinical treatment outcomes of recurrent breast cancer with a limited number of isolated lung metastases, and to evaluating the role of pulmonary metastasectomy.
Identification and characterization of a novel cancer/testis antigen gene CAGE
Bomsoo Cho,Yoon Lim,Dae-Yeon Lee,Saeyoung Park,Hosoon Lee,Woo Ho Kim,Han-Kwang Yang,Yung-Jue Bang,Dooil Jeoung +8 more
TL;DR: It is found that demethylation played a role in the activation of CAGE in some cancer cell lines that do not express it, and this gene can be a target of antitumor immunotherapy.
Pan-Pim Kinase Inhibitor AZD1208 Suppresses Tumor Growth and Synergistically Interacts with Akt Inhibition in Gastric Cancer Cells.
Miso Lee,Kyung Hun Lee,Ahrum Min,Jeongeun Kim,Seongyeong Kim,Hyemin Jang,Jee Min Lim,So Hyeon Kim,Dong Hyeon Ha,Won Jae Jeong,Koung Jin Suh,Yae Won Yang,Tae Yong Kim,Do Youn Oh,Yung-Jue Bang,Seock-Ah Im +15 more
TL;DR: It is found that cells damaged by Pim inhibition were repaired by activation of the DNA damage repair pathway, which promoted cell survival and led the cells to become resistant to AZD1208.
Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin.
Sun Young Kim,Hwang-Phill Kim,Yu Jung Kim,Do Youn Oh,Seock-Ah Im,Dongsoon Lee,Hyun Soon Jong,Tae-You Kim,Yung-Jue Bang +8 more
TL;DR: It is suggested that trastuzumab combined with chemotherapeutic agents can be active against gastric cancer with HER2 amplification, and the mechanism of the growth inhibition is elucidated.